ArticleInternational journal of preventive medicine2025
The 13-Year Trend of Colorectal Cancer in Isfahan, Iran.
Article in International journal of preventive medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The incidence of colorectal cancer varies from country to country and even among cities in the country. Overall statistics may mask important trends based on sex and age, so the detailed statistics will be more useful. This study aimed to investigate the trend of colorectal cancer from 2007 to the last formal published data (2019) in Isfahan, Iran. Method: Colorectal cancer incidence and age-standardized rate were calculated using both data from the Isfahan Cancer Registration Center and Iran and World Standard Population. STATA software was used to calculate the frequency and incidence rates as well as ASR. Results: The total number of diagnosed CRC cases changed from 344 to 1093 between 2007 and 2019 in Isfahan Province. About 55% of all new cases were men, and they also were older on the average than women when diagnosed with cancer. Crude rate and ASR of CRC increased from 9.6 in 2007 to 27 and 22.6 in 2019 per 100,000. Conclusions: Although we have observed an increase in the trend of colorectal cancer (CRC) cases, this trend is heavily dependent on cancer registration policies. This should be taken into account by policymakers, as to make an accurate judgment of the trend, a comprehensive, unified, and high-quality registration policy must be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.